A Dark Vector Cognition product

Item 1A. Risk Factors

3K characters. Original on sec.gov · Markdown

Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022.

Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth a summary of our purchases during the quarter ended March 31, 2023, of equity securities that are registered by MPC pursuant to Section 12 of the Securities Exchange Act of 1934, as amended.

Millions of Dollars
PeriodTotal Number of Shares Purchased(a)Average Price Paid per Share(b)Total Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs(c)(d)
01/01/2023-01/31/20236,124,238$120.296,124,175$7,595
02/01/2023-02/28/20237,777,353124.647,777,1746,626
03/01/2023-03/31/202311,685,051128.3811,685,0515,126
Total25,586,642125.3125,586,400

(a)The amounts in this column include 63, 179 and 0 shares of our common stock delivered by employees to MPC, upon vesting of restricted stock, to satisfy tax withholding requirements in January, February and March, respectively.

(b)Amounts in this column reflect the weighted average price paid for shares repurchased under our share repurchase authorizations and for shares tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock granted under our stock plans. The weighted average price includes any commissions paid to brokers during the quarter.

(c)On August 2, 2022, we announced that our board of directors had approved a $5.0 billion share repurchase authorization. On January 31, 2023, we announced that our board of directors had approved an additional $5.0 billion share repurchase authorization. On May 2, 2023, we announced that our board of directors had approved an additional $5.0 billion share repurchase authorization. These share repurchase authorizations have no expiration date.

(d)Includes the payment of any commissions paid to brokers during the quarter.

Table of Contents

Previous: Item 4. Controls and Procedures · Next: Item 6. Exhibits